Sinofn Health
Sinofn Health
In the rapidly evolving landscape of global health, SINOFN Health Co., Ltd. stands as a beacon of scientific rigor and manufacturing excellence. As the strategic OEM arm of the SINOFN Group—a national high-tech enterprise established in 2012 and academically anchored by the Chinese Academy of Sciences (CAS)—we provide more than just contract manufacturing; we provide a bridge between clinical research and consumer-ready health solutions.
Operating from the global hub of Shanghai, SINOFN bridges the gap between China's massive supply chain resilience and the stringent quality demands of international markets. Our approach integrates Precision Nutrition, Molecular Biology, and Industry 4.0 Smart Manufacturing to ensure that every product—from NMN longevity precursors to specialized PKU medical foods—delivers maximal bioavailability and safety.
Our authority is rooted in a leadership team that combines medical practice with advanced biotechnological research. We don't just "mix ingredients"; we engineer delivery systems.
Leveraged clinical experience in metabolic disorders to pioneer affordable PKU (Phenylketonuria) food solutions. Her mission: "Profit with Purpose."
Ph.D. from Peking University Medical School. 15+ years specializing in metabolic disorder formulations and clinical nutrition protocols.
Associate Researcher at the Chinese Academy of Sciences. Specialist in bioactive compound delivery systems and micro-encapsulation technologies.
Senior Scientist with decades of experience in EU regulatory landscapes and cutting-edge nutraceutical delivery technologies.
In the post-pandemic era, Supply Chain Resilience is the most critical factor for global brand growth. SINOFN’s 53,000㎡ manufacturing facility represents the pinnacle of "Smart Factory" integration.
We serve the entire spectrum of the health market with specialized solutions tailored to modern consumer intent:
Deep expertise in Foods for Special Medical Purposes (FSMP), particularly for PKU and metabolic disorders. Compliance with highest medical safety standards.
Utilizing high-purity NMN (≥99%) and PQQ to address the booming "Bio-hacking" and healthy aging markets globally.
Advanced formulations using GABA, Phosphatidylserine, and Jujube-derived cAMP to tackle the global mental wellness and sleep crisis.
Harnessing the power of Tremella Polysaccharides and Snow Fungus through patented extraction processes for "Beauty from Within."
Implementation of nano-emulsion and liposomal delivery systems to increase the absorption rates of poorly soluble nutrients like Curcumin and CoQ10 by up to 500%.
Deploying machine learning algorithms to predict ingredient synergies and stability, drastically reducing the R&D cycle for new ODM products.
Developing automated production lines capable of "Batch of One" manufacturing, tailored to individual genetic profiles or blood data for enterprise health partners.
Entering a new market requires more than just a product; it requires a regulatory passport. SINOFN provides full-spectrum support for:
Our "Global-Local" strategy ensures that formulations are pre-adjusted for FDA (USA), EFSA (EU), and TGA (Australia) standards before the first batch is even produced. This reduces regulatory rejection risks and speeds up market entry for our global partners.
We understand the challenges faced by procurement directors at major health enterprises. Our systems are built to solve:
Our massive capital backing and direct raw material sourcing contracts provide price stability in a volatile global market.
With an in-house HPLC/GC-MS testing center, we provide Certificates of Analysis (CoA) that are trusted by the world’s largest brands.
Unlike other giants, we offer pilot-scale prototyping, allowing brands to test "MVP" (Minimum Viable Products) before full-scale launch.
